Cargando…
Elimination of Herpes Simplex Virus-2 and Epstein-Barr Virus With Seraph 100 Microbind Affinity Blood Filter and Therapeutic Plasma Exchange: An Explorative Study in a Patient With Acute Liver Failure
Herpes simplex virus (HSV)-2 is a rare cause of hepatitis that can lead to acute liver failure (ALF) and often death. The earlier the initiation of acyclovir treatment the better the survival. With regard to ALF, controlled randomized data support the use of therapeutic plasma exchange (TPE) both as...
Autores principales: | Andermatt, Rea, Bloemberg, Guido V., Ganter, Christoph C., Mueller, Nicolas J., Mueller, Antonia M. S., Muellhaupt, Beat, Kielstein, Jan T., David, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374189/ https://www.ncbi.nlm.nih.gov/pubmed/35975141 http://dx.doi.org/10.1097/CCE.0000000000000745 |
Ejemplares similares
-
In vitro elimination of anti-infective drugs by the Seraph(®) 100 Microbind(®) affinity blood filter
por: Schmidt, Julius J, et al.
Publicado: (2020) -
Treatment of a Critically Ill COVID-19 Patient with the Seraph 100 Microbind Affinity Filter
por: Pape, Anke, et al.
Publicado: (2021) -
Staphylococcus aureus binding to Seraph(®) 100 Microbind(®) Affinity Filter: Effects of surface protein expression and treatment duration
por: Seffer, Malin-Theres, et al.
Publicado: (2023) -
Interim analysis of the COSA (COVID-19 patients treated with the Seraph(®) 100 Microbind(®) Affinity filter) registry
por: Schmidt, Julius J, et al.
Publicado: (2021) -
Safety and efficacy of the Seraph® 100 Microbind® Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study
por: Eden, Gabriele, et al.
Publicado: (2022)